Publication | Open Access
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance
29
Citations
46
References
2021
Year
Tumor BiologyHepatologyMedicineNovel TargetSorafenib ResistancePathologyLiver CancerTumor SuppressorCancer BiologyCell BiologyHepatocellular CarcinomaCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1